StockData
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc (ALXO) stock

ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.97−0.03 (-3.47%)

Close on Nov 18, 2026Market cap $134.14MP/E –Yield –

Earnings

ALX Oncology's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 6, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
–
EPS, Q2 FY2026
-$0.13
-$0.49 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of ALX Oncology's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 6, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 6, 2026before the open––-$0.13Release
Q1 FY2026ended Mar 31, 2026May 8, 2026before the open––-$0.17Release
Q4 FY2025ended Dec 31, 2025Feb 27, 2026before the open––-$0.42Release
Q3 FY2025ended Sep 30, 2025Nov 7, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025after the close––-$0.49Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 6, 2025after the close––-$0.55Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024after the close––-$0.58Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close––-$0.76Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close––-$0.71Release
Q4 FY2023ended Dec 31, 2023Mar 7, 2024after the close––-$0.93Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

ALX Oncology has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When ALX Oncology puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases ALX Oncology filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Update
  6. Results
  7. News
  8. News
  9. Results
  10. News
  11. Results
  12. Results
  13. Results
  14. Update
  15. Update

See a number that looks wrong?